EGFR Mutation: Significance as a Stratification Factor in the Era of Molecular-Targeted Therapy

Oncology Letters - Greece
doi 10.3892/ol.2011.240
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Personalized Molecular Targeted Therapy for Hepatocellular Carcinoma in the Era of Genome Sequencing

Translational Cancer Research
Cancer ResearchOncologyRadiologyNuclear MedicineImaging
2016English

Predicting Efficacy and Toxicity in the Era of Targeted Therapy: Focus on Anti-Egfr and Anti-Vegf Molecules

Current Drug Metabolism
Clinical BiochemistryPharmacology
2011English

Risk Stratification of Childhood Medulloblastoma in the Molecular Era: The Current Consensus

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2016English

Targeted Molecular Therapy in Glioblastoma

Journal of Oncology
Oncology
2020English

Esophageal Adenocarcinoma: Treatment Modalities in the Era of Targeted Therapy

Digestive Diseases and Sciences
PhysiologyGastroenterology
2010English

EGFR Mutation Testing: Changing Patterns of Molecular Testing in Brazil

Oncologist
Cancer ResearchMedicineOncology
2018English

Treating Penile Cancer in the Immunotherapy and Targeted Therapy Era

Case Reports in Oncological Medicine
Oncology
2019English

Lung Adenocarcinoma: Guiding EGFR-targeted Therapy and Beyond

Modern Pathology
Forensic MedicinePathology
2008English

Real-World Experience of Afatinib as a First-Line Therapy for Advanced EGFR Mutation-Positive Lung Adenocarcinoma

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy